Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1927 2
1928 3
1929 3
1930 5
1931 2
1932 5
1933 2
1934 2
1935 1
1936 2
1939 1
1942 1
1946 1
1952 1
1953 1
1954 1
1956 2
1957 1
1959 1
1963 1
1964 4
1966 3
1968 3
1971 1
1972 2
1973 3
1974 2
1975 4
1976 1
1977 2
1978 1
1979 1
1983 4
1984 6
1985 5
1986 6
1987 3
1988 3
1989 4
1991 2
1992 5
1993 5
1994 6
1995 7
1996 8
1997 7
1998 5
1999 5
2000 7
2001 12
2002 11
2003 9
2004 17
2005 12
2006 13
2007 19
2008 25
2009 33
2010 19
2011 26
2012 22
2013 30
2014 25
2015 36
2016 49
2017 48
2018 67
2019 59
2020 58
2021 52
2022 41
2023 71
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

849 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Juarez-Smith
Page 1
Ultrasound assessment of gastric content and volume.
Van de Putte P, Perlas A. Van de Putte P, et al. Br J Anaesth. 2014 Jul;113(1):12-22. doi: 10.1093/bja/aeu151. Epub 2014 Jun 3. Br J Anaesth. 2014. PMID: 24893784 Free article. Review.
Pericapsular Nerve Group (PENG) Block for Hip Fracture.
Girón-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Girón-Arango L, et al. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847. Reg Anesth Pain Med. 2018. PMID: 30063657
Diagnostic Accuracy of Point-of-Care Gastric Ultrasound.
Kruisselbrink R, Gharapetian A, Chaparro LE, Ami N, Richler D, Chan VWS, Perlas A. Kruisselbrink R, et al. Anesth Analg. 2019 Jan;128(1):89-95. doi: 10.1213/ANE.0000000000003372. Anesth Analg. 2019. PMID: 29624530 Clinical Trial.
Editors' commentary.
Sites BD, Brummett CM, Buvanendran A, Capdevila X, Cohen SP, Guan Y, Liu S, Memtsoudis SG, Perlas A, Tran Q, Wu CL. Sites BD, et al. Reg Anesth Pain Med. 2020 Oct;45(10):755-756. doi: 10.1136/rapm-2020-101932. Epub 2020 Aug 11. Reg Anesth Pain Med. 2020. PMID: 32784229 No abstract available.
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial.
Lim SM, Peters S, Ortega Granados AL, Pinto GDJ, Fuentes CS, Lo Russo G, Schenker M, Ahn JS, Reck M, Szijgyarto Z, Huseinovic N, Zografos E, Buss E, Stjepanovic N, O'Donnell S, de Marinis F. Lim SM, et al. Nat Commun. 2023 Nov 11;14(1):7301. doi: 10.1038/s41467-023-42900-4. Nat Commun. 2023. PMID: 37951954 Free PMC article. Clinical Trial.
PERLA is a global, double-blind, parallel phase II trial (NCT04581824) comparing efficacy and safety of anti-PD-1 antibodies dostarlimab and pembrolizumab, plus chemotherapy (DCT and PCT, respectively) as first-line treatment in patients with metastatic non-squamous NSCLC
PERLA is a global, double-blind, parallel phase II trial (NCT04581824) comparing efficacy and safety of anti-PD-1 antibodies dostarli
Perioperative point-of-care gastric ultrasound.
El-Boghdadly K, Wojcikiewicz T, Perlas A. El-Boghdadly K, et al. BJA Educ. 2019 Jul;19(7):219-226. doi: 10.1016/j.bjae.2019.03.003. Epub 2019 Apr 24. BJA Educ. 2019. PMID: 33456894 Free PMC article. Review. No abstract available.
849 results